中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
12期
133-135
,共3页
心源性脑栓塞%致病因素%分析%治疗效果
心源性腦栓塞%緻病因素%分析%治療效果
심원성뇌전새%치병인소%분석%치료효과
Cardiogenic cerebral embolism%Pathogenic factors%Analysis%Treatment effect
目的：探讨心源性脑栓塞的致病因素和临床治疗效果。方法回顾性分析2013年4月~2014年7月间收治的89例心源性脑栓塞患者的临床资料，总结和归纳心源性脑栓塞的相关致病因素，并分析临床疗效。结果心源性脑栓塞的常见病有：心房纤颤35例（39.3%）、心瓣膜病29例（32.6%）、心肌梗死13例（14.6%）、其他12例（13.5%）；通过对症治疗后，总有效率达到95.5%。结论导致心源性脑栓塞的因素较多，其中主要致病因素是心房纤颤动和心瓣膜病，临床中应该给予针对性的预防和治疗，提高临床疗效，改善患者的生存和生活质量。
目的：探討心源性腦栓塞的緻病因素和臨床治療效果。方法迴顧性分析2013年4月~2014年7月間收治的89例心源性腦栓塞患者的臨床資料，總結和歸納心源性腦栓塞的相關緻病因素，併分析臨床療效。結果心源性腦栓塞的常見病有：心房纖顫35例（39.3%）、心瓣膜病29例（32.6%）、心肌梗死13例（14.6%）、其他12例（13.5%）；通過對癥治療後，總有效率達到95.5%。結論導緻心源性腦栓塞的因素較多，其中主要緻病因素是心房纖顫動和心瓣膜病，臨床中應該給予針對性的預防和治療，提高臨床療效，改善患者的生存和生活質量。
목적：탐토심원성뇌전새적치병인소화림상치료효과。방법회고성분석2013년4월~2014년7월간수치적89례심원성뇌전새환자적림상자료，총결화귀납심원성뇌전새적상관치병인소，병분석림상료효。결과심원성뇌전새적상견병유：심방섬전35례（39.3%）、심판막병29례（32.6%）、심기경사13례（14.6%）、기타12례（13.5%）；통과대증치료후，총유효솔체도95.5%。결론도치심원성뇌전새적인소교다，기중주요치병인소시심방섬전동화심판막병，림상중응해급여침대성적예방화치료，제고림상료효，개선환자적생존화생활질량。
ObjectiveTo investigate the cardiogenic cerebral embolism (CCE) pathogenic factors and clinical therapeutic effect. Methods89 patients with cardiogenic cerebral embolism treated in our hospital from April 2013 to July 2014 were retrospectively analyzed, related pathogenic factors of cardiogenic cerebral embolism were summarized, and the clinical curative effect was analyzed.Results The common disease of cardiogenic cerebral embolism were: 35 cases of atrial fibrillation were (39.3%), 29 cases with valvular disease were (32.6%), 13 cases of myocardial infarction were (14.6%), the other 12 cases were (13.5%); by symptomatic treatment, the total effective rate reached 95.5%. Conclusion The cause of cardiogenic cerebral embolism (CCE) many factors, of which the main pathogenic factor is the atrial fibrillation and heart valve disease, clinical should be targeted at the prevention and treatment, improve the clinical efficacy, improve survival and quality of life.
